Publicacións nas que colabora con Gustavo Puras Ochoa (58)

2024

  1. Carbon-Based Nanostructures as Emerging Materials for Gene Delivery Applications

    Pharmaceutics, Vol. 16, Núm. 2

  2. Comparative analysis of lipid-peptide nanoparticles prepared via microfluidics, reverse phase evaporation, and ouzo techniques for efficient plasmid DNA delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 201

  3. Expanding the horizon of transient CAR T therapeutics using virus-free technology

    Biotechnology Advances, Vol. 72

2023

  1. 3D Bioprinting for Musculoskeletal Applications

    3D Printing and Bioprinting for Pharmaceutical and Medical Applications (CRC Press), pp. 147-168

  2. 3D Bioprinting for Ocular Applications

    3D Printing and Bioprinting for Pharmaceutical and Medical Applications (CRC Press), pp. 221-245

  3. An SPM-Enriched Marine Oil Supplement Shifted Microglia Polarization toward M2, Ameliorating Retinal Degeneration in rd10 Mice

    Antioxidants, Vol. 12, Núm. 1

  4. Assessment of Different Niosome Formulations for Optogenetic Applications: Morphological and Electrophysiological Effects

    Pharmaceutics, Vol. 15, Núm. 7

  5. Bektore ez-biral lipidikoak garatzeko erabiltzen diren teknikak eta hauen garrantzia etorkizunerako

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

  6. Erratum: Nanodiamonds Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases (ACS Appl. Mater. Interfaces (2022) 14:11 (13665−13677) DOI: 10.1021/acsami.2c02182)

    ACS Applied Materials and Interfaces

  7. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior

    Biomolecules, Vol. 13, Núm. 11

  8. Long-term biophysical stability of nanodiamonds combined with lipid nanocarriers for non-viral gene delivery to the retina

    International Journal of Pharmaceutics, Vol. 639

  9. Stability of polymeric cationic niosomes and their plasmid DNA-based complexes as gene delivery carriers

    Drug Delivery, Vol. 30, Núm. 1

  10. Stem Cell-Derived Extracellular Vesicles as a Potential Therapeutic Tool for Eye Diseases: From Benchtop to Bedside

    Advances in experimental medicine and biology, Vol. 1410, pp. 127-143

  11. The role of microfluidics and 3D-bioprinting in the future of exosome therapy

    Trends in Biotechnology, Vol. 41, Núm. 11, pp. 1343-1359

2022

  1. Design of double functionalized carbon nanotube for amphotericin B and genetic material delivery

    Scientific Reports, Vol. 12, Núm. 1

  2. Nanodiamond Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases

    ACS Applied Materials and Interfaces, Vol. 14, Núm. 11, pp. 13665-13677

  3. Therapeutic Opportunities and Delivery Strategies for Brain Revascularization in Stroke, Neurodegeneration, and Aging

    Pharmacological reviews, Vol. 74, Núm. 2, pp. 439-461

2021

  1. Applying 3D constructs for gene therapy

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 93-95

  2. Correlation between biophysical properties of niosomes elaborated with chloroquine and different tensioactives and their transfection efficiency

    Pharmaceutics, Vol. 13, Núm. 11

  3. Current insights into 3D bioprinting: An advanced approach for eye tissue regeneration

    Pharmaceutics, Vol. 13, Núm. 3, pp. 1-28